Novartis (NVS) Misses Q4 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Novartis (NVS) slides as Q4 EPS, revenue miss estimates
January 31, 2024 7:30 AM ESTNovartis (NYSE: NVS) stock fell 4% in premarket trading Wednesday after the Swiss pharmaceutical company reported worse-than-expected core earnings for the fourth quarter.
Concretely, Novartis posted Q4 core earnings per share (EPS) of $1.53, missing the consensus projection of $1.66. Revenue came in at $11.42 billion, also below the estimated... More
